» Articles » PMID: 21576246

The Solution Structure of Heparan Sulfate Differs from That of Heparin: Implications for Function

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 May 18
PMID 21576246
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments degree of polymerization 6-18 (dp6-dp18) and dp24, corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s(20,)(w) of HS dp6-dp24 showed a small rotor speed dependence, where similar s(20,)(w) values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radius of gyration (R(G)) values from 1.03 to 2.82 nm, cross-sectional radius of gyration (R(XS)) values from 0.31 to 0.65 nm, and maximum lengths (L) from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5000-8000 conformationally randomized HS structures gave best fit dp6-dp16 molecular structures that were longer and more bent than their equivalents in heparin. No fits were obtained for HS dp18 or dp24, indicating their higher flexibility. We conclude that HS displays an extended bent conformation that is significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.

Citing Articles

An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure.

Beccati D, Lech M, Ozug J, Gunay N, Wang J, Sun E Glycoconj J. 2016; 34(1):107-117.

PMID: 27771794 PMC: 5266780. DOI: 10.1007/s10719-016-9734-7.


: a suite of programs for comparing atomistic models with small-angle scattering data.

Wright D, Perkins S J Appl Crystallogr. 2015; 48(Pt 3):953-961.

PMID: 26089768 PMC: 4453981. DOI: 10.1107/S1600576715007062.


Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands.

Perkins S, Fung K, Khan S Front Immunol. 2014; 5:126.

PMID: 24744754 PMC: 3978290. DOI: 10.3389/fimmu.2014.00126.


Large-scale investigation of Leishmania interaction networks with host extracellular matrix by surface plasmon resonance imaging.

Fatoux-Ardore M, Peysselon F, Weiss A, Bastien P, Pratlong F, Ricard-Blum S Infect Immun. 2014; 82(2):594-606.

PMID: 24478075 PMC: 3911396. DOI: 10.1128/IAI.01146-13.


The solution structure of heparan sulfate differs from that of heparin: implications for function.

Khan S, Fung K, Rodriguez E, Patel R, Gor J, Mulloy B J Biol Chem. 2013; 288(39):27737-51.

PMID: 23921391 PMC: 3784691. DOI: 10.1074/jbc.M113.492223.


References
1.
Gilbert H, Asokan R, Holers V, Perkins S . The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. J Mol Biol. 2006; 362(5):1132-47. DOI: 10.1016/j.jmb.2006.08.012. View

2.
Schuck P . Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000; 78(3):1606-19. PMC: 1300758. DOI: 10.1016/S0006-3495(00)76713-0. View

3.
Mulloy B, Forster M . Conformation and dynamics of heparin and heparan sulfate. Glycobiology. 2000; 10(11):1147-56. DOI: 10.1093/glycob/10.11.1147. View

4.
Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U . Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer. 2002; 2(7):521-8. DOI: 10.1038/nrc842. View

5.
Stringer S, Forster M, Mulloy B, Bishop C, Graham G, Gallagher J . Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood. 2002; 100(5):1543-50. View